Desmoglein 2 (Dsg2)mut/mut mice were used as the ARVC model to verify the therapeutic effects of pharmacological intervention on identified cellular cluster. The gene discussed is DSG2; the disease is arrhythmogenic right ventricular cardiomyopathy.